Overview
Introduction
Tropical diseases account for around 5 million deaths per year (WHO, 2002). Major contributors to
these numbers are the mosquito borne diseases, which include West Nile Fever, Japanese Encephalitis,
Yellow Fever, Dengue and Malaria. Small pox, caused by the Variola virus, although officially
eradicated since 1980, still poses a distinct threat as part of bioterrorist attack.
Scope
- Comparative analysis of epidemiology, current disease management and unmet needs analysis in
five selected tropical diseases
- Characterization of existing vaccines and demand drivers for newer generation products in
smallpox, yellow fever and Japanese encephalitis
- Critical overview of need for preventative vaccination in malaria, dengue and West Nile River
virus
- Ball park estimation of selected vaccine revenue potential per target segment
Report Highlights
Despite their enormous impact on global health, preventative vaccination in the five major
tropical diseases is either non-existent or outdated.
The increased incidence and geographical spread of tropical diseases coupled with elevated
international travel, urbanization and the threat of bio-terrorism demands for increased levels of
preventative action.
Bearing in mind existing revenues, smallpox stockpiling and maintenance and newer vaccines,
Datamonitor estimates the tropical defense segment can provide an additional $2.6-2.9 billion over
the next 7-10 years.
Reasons to Purchase
- Compare and contrast epidemiological parameters of five major tropical diseases and their global
impact on human health
- Understand drivers for newer generation smallpox vaccines and demands of the US BioShield Act
- Understand the benefits and limitations of existing vaccines and need for further preventative
measures in target groups
View Cart
